Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies.

Mol Ther Oncolytics · 2021 · PMC7851498 · PMID 33575469

Europe PMC DOI

hedged sentence

0.0240

closest p · 0.5× alpha

0.0240

boldest claim

The sentences

an increasing trendp = 0.024actually significant

In addition, regarding the representative molecular biomarkers for gliomas, the mutation frequency of BRAF showed a declining trend (p < 0.001), whereas that of H3K27M showed an increasing trend (p = 0.024) from IS-I to IS-III.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.